FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23605011000001108: Neisseria meningitidis group B NadA protein (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Dec 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
76960501000001110 Neisseria meningitidis group B NadA protein (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76960601000001114 Neisseria meningitidis group B NadA protein en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neisseria meningitidis group B NadA protein Is a Antigen of Neisseria meningitidis serogroup B true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (CST Pharma Ltd) 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (CST Pharma Ltd) Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) 10 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Generic Bexsero vaccine suspension for injection 0.5ml pre-filled syringes 10 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Meningococcal group B vaccine (rDNA, component, adsorbed) suspension for injection 0.5ml pre-filled syringes Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (Novartis Vaccines and Diagnostics Ltd) Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Meningococcal group B vaccine (rDNA, component, adsorbed) suspension for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (Novartis Vaccines and Diagnostics Ltd) 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group B NadA protein Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start